Greetings and welcome to the STAAR Surgical Fourth Quarter 2024 Earnings Webcast. As a reminder, this event is being recorded today Tuesday, February 11th, 2025. During today's presentation, all ...

STAAR Surgical's Q4 results were severely impacted by lower demand and high inventory levels in China. Check out why I ...

Reports Q4 revenue $49.0M vs. $76.3M last year. “STAAR’s fiscal 2024 results reflect fluctuating demand in China, which more than offset the ...

LAKE FOREST, Calif. - STAAR Surgical Company (NASDAQ: STAA) shares tumbled 32.9% after the vision correction device maker reported fourth-quarter results that fell far short of analyst expectations ...

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the fourth ...

The modern facility, equipped with cutting-edge equipment and an operating theatre, is expected to provide specialized eye treatment to Ugandans, reducing the need for overseas treatment Thank you for ...

Evidence suggests ancient civilizations, including the Greeks, may have had early optical knowledge and devices like ...

Atropine therapy has a direct treatment effect on choroidal thickness, which cannot be fully explained by axial length or SER changes.

Despite a net loss and challenges in China, Staar Surgical Co (STAA) sees growth in ICL sales outside China and maintains a ...

EQS-News: Carl Zeiss Meditec AG / Key word (s): Quarterly / Interim Statement/Quarter Results Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25 12.02.2025 / 06:58 ...

Opus Genetics (NASDAQ:IRD – Get Free Report) is one of 1,064 public companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its rivals? We will compare Opus ...

Optometrists may not surgically repair macular holes, but they play a crucial role in managing visual outcomes in these ...